The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Novel treatments for autistic spectrum disorders
Abstract
In no area of developmental pediatric practice is there more controversy regarding the choice of treatment than related to children with autistic spectrum disorders (ASD). Complementary and alternative medical therapies (CAM) are often elected because they are perceived as treating the cause of symptoms rather than the symptoms themselves. CAM used for autism can be divided by proposed mechanism: immune modulation, gastrointestinal, supplements that affect neurotransmitter function, and nonbiologic intervention. Secretin as a therapy for autism is discussed as an example of how a clinical observation rapidly grew to a widespread treatment before well‐designed studies demonstrated absence of effect. The plausibility for behavioral effect was not substantiated by clinical studies. CAM used for treatment of autism is examined in terms of rationale, evidence of efficacy, side effects, and additional commentary. Families and clinicians need access to well‐designed clinical evidence to assist them in choice of therapies. © 2005 Wiley‐Liss, Inc. MRDD Research Reviews 2005;11:131–142.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wakefield, A., Murch, S., Anthony, A., Linnell, J., Casson, D., Malik, M., Berelowitz, M., Dhillon, A., Thomson, M., Harvey, P., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11096-0 · Cited by 3,006
RetractedBehavioral treatment and normal educational and intellectual functioning in young autistic children.
Lovaas, O. I. (1987) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.55.1.3 · Cited by 3,288
Risperidone in Children with Autism and Serious Behavioral Problems
McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., Arnold, L. E., Lindsay, R., Nash, P., Hollway, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013171 · Cited by 1,574 · cited 1×
“An example is the Research Units in Pediatric Psychopharmacology (RUPP) trial demonstrating the efficacy of risperidone for treatment of irritability and aggression [McCracken et al., 2002].”
MethodMuhle, R., Trentacoste, S. V., & Rapin, I. (2004) · Pediatrics · doi:10.1542/peds.113.5.e472 · Cited by 1,207
Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring
Shi, L., Fatemi, S. H., Sidwell, R. W., & Patterson, P. H. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00297.2003 · Cited by 1,025 · cited 1×
“…or autoimmune disorders [Bailey et al., 1998], antibodies directed toward endothelial cells, neurofilaments, and myelin basic protein have been reported in children with autism [Pliopys et al., 1989; Singh et al., 1993, 1998; Connolly et al., 1999; Singh et al., 2002; Singh and Jensen, 2003].”
BackgroundGastrointestinal Microflora Studies in Late‐Onset Autism
Finegold, S. M., Molitoris, D., Song, Y., Liu, C., Vaisanen, M., Bolte, E., McTeague, M., Sandler, R., Wexler, H., Marlowe, E. M., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/341914 · Cited by 742
Plasma oxytocin levels in autistic children
Modahl, C., Green, L. A., Fein, D., Morris, M., Waterhouse, L., Feinstein, C., & Levin, H. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00439-3 · Cited by 728
Oxytocin Infusion Reduces Repetitive Behaviors in Adults with Autistic and Asperger's Disorders
Hollander, E., Novotny, S., Hanratty, M., Yaffe, R., DeCaria, C. M., Aronowitz, B. R., & Mosovich, S. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300021 · Cited by 689 · cited 1×
“Increased stereotyped behavior following intracerbroventricular oxytocin administration has also been demonstrated in an animal model [Hollander et al., 2003].”
ResultShort-Term Benefit From Oral Vancomycin Treatment of Regressive-Onset Autism
Sandler, R. H., Finegold, S. M., Bolte, E. R., Buchanan, C. P., Maxwell, A. P., Väisänen, M.-L., Nelson, M. N., & Wexler, H. M. (2000) · Journal of Child Neurology · doi:10.1177/088307380001500701 · Cited by 614 · cited 1×
“Oral vancomycin [Sandler et al., 2000] was given in an open label study to 11 children with ASD who had a history of behavioral regression and diarrhea.”
Real-Time PCR Quantitation of Clostridia in Feces of Autistic Children
Song, Y., Liu, C., & Finegold, S. M. (2004) · Applied and Environmental Microbiology · doi:10.1128/aem.70.11.6459-6465.2004 · Cited by 556 · cited 1×
“When the stools of children with autism were compared to children without autism, colonization with clostridium species were different [Finegold et al., 2002; Song et al., 2004].”
BackgroundAbnormal intestinal permeability in children with autism
D'Eufemia, P., Celli, M., Finocchiaro, R., Pacifico, L., Viozzi, L., Zaccagnini, M., Cardi, E., & Giardini, O. (1996) · Acta Paediatrica · doi:10.1111/j.1651-2227.1996.tb14220.x · Cited by 416
Oxytocin and autistic disorder: alterations in peptide forms
Green, L., Fein, D., Modahl, C., Feinstein, C., Waterhouse, L., & Morris, M. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01139-8 · Cited by 404
Whole blood serotonin in autistic and normal subjects
Anderson, G. M., Freedman, D. X., Cohen, D. J., Volkmar, F. R., Hoder, E. L., McPhedran, P., Minderaa, R. B., Hansen, C. R., & Young, J. G. (1987) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1987.tb00677.x · Cited by 313
Autism and gastrointestinal symptoms
Horvath, K., & Perman, J. A. (2002) · Current Gastroenterology Reports · doi:10.1007/s11894-002-0071-6 · Cited by 260
Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism
Gupta, S., Aggarwal, S., Rashanravan, B., & Lee, T. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00021-6 · Cited by 250 · cited 1×
“…cytotoxicity [Warren et al., 1987]; alteration in CD 4:CD 8 [Warren et al., 1986; Plioplys et al., 1994]; lower levels of Th1 cells and resultant lower levels of IL2, IFNgamma, and natural killer cell activity [Gupta et al., 1998]; and decreased tissue necrosis factor alpha [Torres et al., 2001].”
Oxytocin, vasopressin, and autism: Is there a connection?
Insel, T. R., O’Brien, D. J., & Leckman, J. F. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00142-5 · Cited by 226
Immune abnormalities in patients with autism
Warren, R. P., Margaretten, N. C., Pace, N. C., & Foster, A. (1986) · Journal of Autism and Developmental Disorders · doi:10.1007/bf01531729 · Cited by 207 · cited 1×
“Reported findings include decreased natural killer cell cytotoxicity [Warren et al., 1987]; alteration in CD 4:CD 8 [Warren et al., 1986; Plioplys et al., 1994]; lower levels of Th1 cells and resultant lower levels of IL2, IFNgamma, and natural killer cell activity [Gupta et al., 1998]; and…”
BackgroundVojdani, A., Campbell, A. W., Anyanwu, E., Kashanian, A., Bock, K., & Vojdani, E. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00180-7 · Cited by 197
Reduced Natural Killer Cell Activity in Autism
WARREN, R. P., FOSTER, A., & MARGARETTEN, N. C. (1987) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198705000-00008 · Cited by 190 · cited 1×
“Reported findings include decreased natural killer cell cytotoxicity [Warren et al., 1987]; alteration in CD 4:CD 8 [Warren et al., 1986; Plioplys et al., 1994]; lower levels of Th1 cells and resultant lower levels of IL2, IFNgamma, and natural killer cell activity [Gupta et al., 1998]; and…”
BackgroundFacilitated Communication Since 1995: A Review of Published Studies
Mostert, M. P. (2001) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1010795219886 · Cited by 175
A preliminary trial of ascorbic acid as supplemental therapy for autism
Dolske, M. C., Spollen, J., McKay, S., Lancashire, E., & Tolbert, L. (1993) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(93)90058-z · Cited by 168
Lymphocyte Function in Autism and Rett Syndrome
Plioplys, A. V., Greaves, A., Kazemi, K., & Silverman, E. (2008) · Neuropsychobiology · doi:10.1159/000119056 · Cited by 112
Brief report: Ear infections in autistic and normal children
Konstantareas, M. M., & Homatidis, S. (1987) · Journal of Autism and Developmental Disorders · doi:10.1007/bf01486973 · Cited by 108
Singh, V. K., Singh, E. A., & Warren, R. P. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00522-7 · Cited by 99
Cited by
Management of Children With Autism Spectrum Disorders
Myers, S. M., Johnson, C. P., & the Council on Children With Disabilities (2007) · Pediatrics · doi:10.1542/peds.2007-2362 · Cited by 1,125
Pyrosequencing study of fecal microflora of autistic and control children
Finegold, S. M., Dowd, S. E., Gontcharova, V., Liu, C., Henley, K. E., Wolcott, R. D., Youn, E., Summanen, P. H., Granpeesheh, D., Dixon, D., et al. (2010) · Anaerobe · doi:10.1016/j.anaerobe.2010.06.008 · Cited by 977
Psychological Treatments That Cause Harm
Lilienfeld, S. O. (2007) · Perspectives on Psychological Science · doi:10.1111/j.1745-6916.2007.00029.x · Cited by 959
Incidence of Gastrointestinal Symptoms in Children With Autism: A Population-Based Study
Ibrahim, S. H., Voigt, R. G., Katusic, S. K., Weaver, A. L., & Barbaresi, W. J. (2009) · PEDIATRICS · doi:10.1542/peds.2008-2933 · Cited by 298
Cultural Influences on Perceptions of Health, Illness, and Disability: A Review and Focus on Autism
Ravindran, N., & Myers, B. J. (2012) · Journal of Child and Family Studies · doi:10.1007/s10826-011-9477-9 · Cited by 240
Metadata
- Authors
- Levy, S. E., & Hyman, S. L.
- Venue
- Mental Retardation and Developmental Disabilities Research Reviews
- Publisher
- Wiley
- Published
- 2005-04
- Volume
- 11
- Issue
- 2
- Pages
- 131-142
- ISSN
- 1080-4013 (ISSN-L)
- 1098-2779
- OpenAlex
- W2166477990
- Cited by
- 171
- References
- 24
- FWCI
- 5.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.